Jump to content

Joel Habener: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Authority control, stub tag
Added {{Cleanup bare URLs}} tag (TW)
Line 1: Line 1:
{{Cleanup bare URLs|date=August 2020}}
'''Joel Habener''' is a Professor of Medicine at [[Harvard Medical School]] who has done fundamental studies on elucidating the role of [[incretin]] hormones such as [[Glucagon-like peptide-1|Glucagon-like peptide-1 (GLP-1)]] and [[Glucagon-like peptide-2|Glucagon-like peptide-2 (GLP-2)]]. For his discoveries, he was awarded the 2020 [[Warren Alpert Foundation Prize]] along with [[Daniel J. Drucker|Daniel Drucker]] and Jens Juul Holst.<ref>https://warrenalpert.org/prize-recipients</ref> He was elected to the [[National Academy of Sciences]] in 2020.<ref>http://www.nasonline.org/news-and-multimedia/news/2020-nas-election.html</ref>
'''Joel Habener''' is a Professor of Medicine at [[Harvard Medical School]] who has done fundamental studies on elucidating the role of [[incretin]] hormones such as [[Glucagon-like peptide-1|Glucagon-like peptide-1 (GLP-1)]] and [[Glucagon-like peptide-2|Glucagon-like peptide-2 (GLP-2)]]. For his discoveries, he was awarded the 2020 [[Warren Alpert Foundation Prize]] along with [[Daniel J. Drucker|Daniel Drucker]] and Jens Juul Holst.<ref>https://warrenalpert.org/prize-recipients</ref> He was elected to the [[National Academy of Sciences]] in 2020.<ref>http://www.nasonline.org/news-and-multimedia/news/2020-nas-election.html</ref>



Revision as of 22:32, 1 August 2020

Joel Habener is a Professor of Medicine at Harvard Medical School who has done fundamental studies on elucidating the role of incretin hormones such as Glucagon-like peptide-1 (GLP-1) and Glucagon-like peptide-2 (GLP-2). For his discoveries, he was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.[1] He was elected to the National Academy of Sciences in 2020.[2]

References